Gofarana Wilar
Overview
Explore the profile of Gofarana Wilar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilar G, Suhandi C, Fukunaga K, Shigeno M, Kawahata I, Abdulah R, et al.
Pharmacol Res
. 2025 Feb;
213:107641.
PMID: 39894187
Background: Metabolic syndrome (MetS) encompasses metabolic risk factors like elevated blood glucose, abnormal lipid levels, and hypertension. Nanocurcumin, a nanoscale formulation of curcumin, may offer therapeutic benefits for MetS management....
2.
Fitriani N, Wilar G, Narsa A, Elamin K, Wathoni N
Stem Cells Cloning
. 2025 Jan;
18():1-13.
PMID: 39816853
Objective: Chronic wounds are a common clinical problem that necessitate the exploration of novel regenerative therapies. We report a method to investigate the in vitro wound healing capacity of an...
3.
Wilar G, Suhandi C, Wathoni N, Fukunaga K, Kawahata I
Int J Nanomedicine
. 2024 Nov;
19:11357-11378.
PMID: 39524925
Nanoparticle-based drug delivery presents a promising solution in enhancing therapies for neurological diseases, particularly cognitive impairment. These nanoparticles address challenges related to the physicochemical profiles of drugs that hinder their...
4.
Suhandi C, Wilar G, Narsa A, Mohammed A, El-Rayyes A, Muchtaridi M, et al.
Drug Des Devel Ther
. 2024 Oct;
18:4723-4748.
PMID: 39469723
α-Mangostin, initially identified in 1855, is a xanthone derivative compound predominantly located in the pericarp of the mangosteen fruit ( L). This compound is known for its beneficial properties as...
5.
Wilar G, Suhandi C, Fukunaga K, Kawahata I
Heliyon
. 2024 Oct;
10(19):e38229.
PMID: 39381111
The use of drugs off-label for managing COVID-19 offers a potential approach. Among these potential drugs, tofacitinib, a JAK inhibitor, is strongly implicated in its ability to mitigate mortality by...
6.
Alquraisy A, Wilar G, Mohammed A, El-Rayyes A, Suhandi C, Wathoni N
Stem Cells Cloning
. 2024 Sep;
17:5-19.
PMID: 39310304
Various studies have been widely conducted on conditioned medium for the development of anti-aging preparations, including the utilization of stem cells, which present a promising alternative solution. This narrative review...
7.
Wathoni N, Suhandi C, Elamin K, Lesmana R, Hasan N, Mohammed A, et al.
Int J Nanomedicine
. 2024 Aug;
19:8091-8113.
PMID: 39161361
The current treatments for wound healing still exhibit drawbacks due to limited availability at the action sites, susceptibility to degradation, and immediate drug release, all of which are detrimental in...
8.
Diantini A, Alfaqeeh M, Permatasari L, Nurfitriani M, Durotulailah L, Wulandari W, et al.
Pediatric Health Med Ther
. 2024 Jul;
15:243-255.
PMID: 39011322
Cough and cold symptoms (CCS) are common pediatric conditions often treated with over-the-counter (OTC) medications. However, the available knowledge regarding the safety and toxicity of these medications in children is...
9.
Vitamia C, Iftinan G, Latarissa I, Wilar G, Cahyanto A, Elamin K, et al.
Drug Des Devel Ther
. 2024 Apr;
18:1297-1312.
PMID: 38681204
Recurrent aphthous stomatitis (RAS) refers to a sore and frequently recurring inflammation of the oral tissues, distinguished by the presence of small ulcers that cause significant discomfort and cannot be...
10.
Vitamia C, Iftinan G, Latarissa I, Wilar G, Cahyanto A, Mohammed A, et al.
Front Pharmacol
. 2024 Mar;
15:1353503.
PMID: 38434698
Recurrent Aphthous Stomatitis (RAS) is a common ulcerative disease of the oral mucosa which is characterized by pain, and recurrent lesions in the oral cavity. This condition is quite painful,...